Uncertainty & Complexity
How Healthcare Systems Get Their Names – and Why it Matters
"What's in a name? That which we call a rose by any other name would smell just as sweet." Shakespeare...
Read more
How the ‘Test to Treat’ Initiative Aims to Get Ahead of the Next Wave of COVID-19
If a person tests positive and treatment is deemed appropriate, oral antiviral therapy can be prescribed on the spot at...
Read more
Lack of Research Over Long COVID
COVID-19 is now two years old. Along the way, it transitioned from an acute to a chronic condition. In the...
Read more
What is the New COVID-19 Variant BA.2?
While the origin of BA.2 is still unclear, it has become the dominant strain in many countries, including India, Denmark...
Read more
Employer Health Plans Must Adjust to a Hybrid Workforce
Employer health plans have two goals - keep employees happy and productive. As the workforce changes, the way health plans...
Read more
Does Scaring People Work When It Comes To Health Messaging?
A communication researcher explains how it has gone wrong during the COVID-19 pandemic, and what we can do about it.
Read more
Trust Comes When You Admit What You Do Not Know – Lessons From Child Development Research
During the pandemic, public health officials have seemed to operate on this assumption – that confidence conveys is necessary for...
Read more
When Ease-of-use is the Endpoint
Healthcare struggles with thinking fast. We like snap decisions when treating diseases. But in the process, we have forgotten that...
Read more
Why Decision Makers Make Wrong Decisions
In recent weeks, the CDC has struggled with policy reversals and communication errors. Yet its leaders continue to project confidence...
Read more
Healthcare in 2022 Will Be Complex
Healthcare is complex. We like simple. So we try to make healthcare simple, which has worked for now, but not...
Read more
Vaccine Mandates Strike at the Heart of Patient Autonomy
Much has been said about the resistance to vaccine mandates. But beneath the rhetoric is the core issue - the...
Read more
Of Thoughts and Language
The push for healthcare equity has profoundly changed the way we view healthcare, including how we speak in medical settings....
Read more
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more